Molecular Biology of the Cell click for ASCB 2009 Annual Meeting page

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Originally published as MBC in Press, 10.1091/mbc.E03-12-0902 on March 26, 2004

Vol. 15, Issue 6, 2707-2719, June 2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
E03-12-0902v1
15/6/2707    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shi-Wen, X.
Right arrow Articles by Abraham, D. J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shi-Wen, X.
Right arrow Articles by Abraham, D. J

Endothelin-1 Promotes Myofibroblast Induction through the ETA Receptor via a rac/Phosphoinositide 3-Kinase/Akt-dependent Pathway and Is Essential for the Enhanced Contractile Phenotype of Fibrotic Fibroblasts

Xu Shi-Wen *, Yunliang Chen *, Christopher P. Denton *, Mark Eastwood {dagger}, Elisabetta A. Renzoni {ddagger}, George Bou-Gharios §, Jeremy D. Pearson ||, Michael Dashwood ¶, Roland M. du Bois {ddagger}, Carol M. Black *, Andrew Leask * #, and David J Abraham *

* Centre for Rheumatology, Royal Free and University College Medical School, London NW3 2PF, United Kingdom; {dagger} Centre for Tissue Engineering Research, University of Westminster, London W1W 6UM, United Kingdom; {ddagger} Interstitial Lung Disease Unit, Royal Brompton Hospital, Imperial College School of Medicine, London SW3 6LR, United Kingdom; § Department of Medicine, Imperial College London, Hammersmith Campus, London W12 0NN, United Kingdom; || Centre for Cardiovascular Biology and Medicine, GKT School of Biomedical Sciences, King's College London, Guy's Campus, London SE1 1UL, United Kingdom; and Department of Molecular Pathology, Royal Free and University College Medical School, London NW3 2PF, United Kingdom

Submitted December 17, 2003; Revised March 9, 2004; Accepted March 16, 2004
Monitoring Editor: Richard Assoian

The endothelins are a family of endothelium-derived peptides that possess a variety of functions, including vasoconstriction. Endothelin-1 (ET-1) is up-regulated during tissue repair and promotes myofibroblast contraction and migration, hence contributing to matrix remodeling during tissue repair. Here, we show that addition of ET-1 to normal lung fibroblasts induces expression of proteins that contribute to a contractile phenotype, including {alpha}-smooth muscle actin ({alpha}-SMA), ezrin, moesin, and paxillin. We confirm that ET-1 enhances the ability of lung fibroblasts to contract extracellular matrix, a function essential for tissue repair, through induction of de novo protein synthesis. Blockade of the Akt/phosphoinositide 3-kinase (PI3-kinase) pathway with LY294002 and wortmannin prevents the ability of ET-1 to induce {alpha}-SMA, ezrin, paxillin, and moesin and to promote matrix contraction. Dominant negative rac and Akt blocked the ability of ET-1 to promote formation of {alpha}-SMA stress fibers. Using specific ET-1 receptor inhibitors, we show that ET-1 induces collagen matrix contraction through the ETA, but not the ETB, receptor. Relative to normal pulmonary fibroblasts, fibroblasts cultured from scars of patients with the fibrotic disease systemic sclerosis (scleroderma) show enhanced ET-1 expression and binding. Systemic sclerosis lung fibroblasts show increased ability to contract a collagen matrix and elevated expression of the procontractile proteins {alpha}-SMA, ezrin, paxillin, and moesin, which are greatly reduced by antagonizing endogenous ET-1 signaling. Thus, blocking ET-1 or the PI3-kinase/Akt cascades might be beneficial in reducing scar formation in pulmonary fibrosis.


Article published online ahead of print. Mol. Biol. Cell 10.1091/mbc.E03-12-0902. Article and publication date are available at www.molbiolcell.org/cgi/doi/10.1091/mbc.E03-12-0902.

# Corresponding author. E-mail address: a.leask{at}rfc.ucl.ac.uk.




This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
A. Tyndall, M. Matucci-Cerinic, and U. Muller-Ladner
Future targets in the management of systemic sclerosis
Rheumatology, June 1, 2009; 48(suppl_3): iii49 - iii53.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. Liu, M. Kapoor, and A. Leask
Rac1 Expression by Fibroblasts Is Required for Tissue Repair in Vivo
Am. J. Pathol., May 1, 2009; 174(5): 1847 - 1856.
[Abstract] [Full Text] [PDF]


Home page
Circ Heart FailHome page
D. von Lewinski, J. Kockskamper, D. Zhu, H. Post, A. Elgner, and B. Pieske
Reduced Stretch-Induced Force Response in Failing Human Myocardium Caused by Impaired Na+-Contraction Coupling
Circ Heart Fail, January 1, 2009; 2(1): 47 - 55.
[Abstract] [Full Text] [PDF]


Home page
ERRHome page
T. E. King Jr and R. M. du Bois
Elucidating the causes and examining the latest clinical findings in pulmonary fibrosis
Eur. Respir. Rev., December 1, 2008; 17(109): 105 - 107.
[Full Text] [PDF]


Home page
ERRHome page
D. Abraham
Role of endothelin in lung fibrosis
Eur. Respir. Rev., December 1, 2008; 17(109): 145 - 150.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
N. Aden, X. Shiwen, D. Aden, C. Black, A. Nuttall, C. P. Denton, A. Leask, D. Abraham, and R. Stratton
Proteomic analysis of scleroderma lesional skin reveals activated wound healing phenotype of epidermal cell layer
Rheumatology, December 1, 2008; 47(12): 1754 - 1760.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
A. Leask, X. Shi-wen, K. Khan, Y. Chen, A. Holmes, M. Eastwood, C. P. Denton, C. M. Black, and D. J. Abraham
Loss of protein kinase C{epsilon} results in impaired cutaneous wound closure and myofibroblast function
J. Cell Sci., October 15, 2008; 121(20): 3459 - 3467.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
G. S. Bogatkevich, A. Ludwicka-Bradley, C. B. Singleton, J. R. Bethard, and R. M. Silver
Proteomic analysis of CTGF-activated lung fibroblasts: identification of IQGAP1 as a key player in lung fibroblast migration
Am J Physiol Lung Cell Mol Physiol, October 1, 2008; 295(4): L603 - L611.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
C. F. Opitz, R. Ewert, W. Kirch, and D. Pittrow
Inhibition of endothelin receptors in the treatment of pulmonary arterial hypertension: does selectivity matter?
Eur. Heart J., August 2, 2008; 29(16): 1936 - 1948.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
E. Tourkina, M. Richard, P. Gooz, M. Bonner, J. Pannu, R. Harley, P. N. Bernatchez, W. C. Sessa, R. M. Silver, and S. Hoffman
Antifibrotic properties of caveolin-1 scaffolding domain in vitro and in vivo
Am J Physiol Lung Cell Mol Physiol, May 1, 2008; 294(5): L843 - L861.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Iribarne, L. Ogawa, V. Torbidoni, C. M. Dodds, R. A. Dodds, and A. M. Suburo
Blockade of Endothelinergic Receptors Prevents Development of Proliferative Vitreoretinopathy in Mice
Am. J. Pathol., April 1, 2008; 172(4): 1030 - 1042.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. Mishra and M. S. Simonson
Oleate Induces a Myofibroblast-Like Phenotype in Mesangial Cells
Arterioscler. Thromb. Vasc. Biol., March 1, 2008; 28(3): 541 - 547.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
J. Dupuis and M. M. Hoeper
Endothelin receptor antagonists in pulmonary arterial hypertension
Eur. Respir. J., February 1, 2008; 31(2): 407 - 415.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. J. Haurani and P. J. Pagano
Adventitial fibroblast reactive oxygen species as autacrine and paracrine mediators of remodeling: Bellwether for vascular disease?
Cardiovasc Res, September 1, 2007; 75(4): 679 - 689.
[Abstract] [Full Text] [PDF]


Home page
ERRHome page
R. M. du Bois
Blocking endothelin: breaking new ground
Eur. Respir. Rev., August 1, 2007; 16(102): 24 - 29.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
R. Jain, P. W. Shaul, Z. Borok, and B. C. Willis
Endothelin-1 Induces Alveolar Epithelial-Mesenchymal Transition through Endothelin Type A Receptor-Mediated Production of TGF-beta1
Am. J. Respir. Cell Mol. Biol., July 1, 2007; 37(1): 38 - 47.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
S. Liu, X. Shi-wen, L. Kennedy, D. Pala, Y. Chen, M. Eastwood, D. E. Carter, C. M. Black, D. J. Abraham, and A. Leask
FAK Is Required for TGFbeta-induced JNK Phosphorylation in Fibroblasts: Implications for Acquisition of a Matrix-remodeling Phenotype
Mol. Biol. Cell, June 1, 2007; 18(6): 2169 - 2178.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
H.-R. Kang, C. G. Lee, R. J. Homer, and J. A. Elias
Semaphorin 7A plays a critical role in TGF-{beta}1-induced pulmonary fibrosis
J. Exp. Med., May 14, 2007; 204(5): 1083 - 1093.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Leask
TGF{beta}, cardiac fibroblasts, and the fibrotic response
Cardiovasc Res, May 1, 2007; 74(2): 207 - 212.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
S. He, A. Dibas, T. Yorio, and G. Prasanna
Parallel Signaling Pathways in Endothelin-1-Induced Proliferation of U373MG Astrocytoma Cells
Experimental Biology and Medicine, March 1, 2007; 232(3): 370 - 384.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
X. Shi-Wen, F. Rodriguez-Pascual, S. Lamas, A. Holmes, S. Howat, J. D. Pearson, M. R. Dashwood, R. M. du Bois, C. P. Denton, C. M. Black, et al.
Constitutive ALK5-Independent c-Jun N-Terminal Kinase Activation Contributes to Endothelin-1 Overexpression in Pulmonary Fibrosis: Evidence of an Autocrine Endothelin Loop Operating through the Endothelin A and B Receptors.
Mol. Cell. Biol., July 1, 2006; 26(14): 5518 - 5527.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Shi-wen, L. A. Stanton, L. Kennedy, D. Pala, Y. Chen, S. L. Howat, E. A. Renzoni, D. E. Carter, G. Bou-Gharios, R. J. Stratton, et al.
CCN2 Is Necessary for Adhesive Responses to Transforming Growth Factor-beta1 in Embryonic Fibroblasts
J. Biol. Chem., April 21, 2006; 281(16): 10715 - 10726.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
K. R. Stenmark, N. Davie, M. Frid, E. Gerasimovskaya, and M. Das
Role of the Adventitia in Pulmonary Vascular Remodeling
Physiology, April 1, 2006; 21(2): 134 - 145.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
P. Sun, H. Xiong, T. H. Kim, B. Ren, and Z. Zhang
Positive Inter-Regulation between beta-Catenin/T Cell Factor-4 Signaling and Endothelin-1 Signaling Potentiates Proliferation and Survival of Prostate Cancer Cells
Mol. Pharmacol., February 1, 2006; 69(2): 520 - 531.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
Y. Chen, X. Shi-wen, J. van Beek, L. Kennedy, M. McLeod, E. A. Renzoni, G. Bou-Gharios, S. Wilcox-Adelman, P. F. Goetinck, M. Eastwood, et al.
Matrix Contraction by Dermal Fibroblasts Requires Transforming Growth Factor-{beta}/Activin-Linked Kinase 5, Heparan Sulfate-Containing Proteoglycans, and MEK/ERK: Insights into Pathological Scarring in Chronic Fibrotic Disease
Am. J. Pathol., December 1, 2005; 167(6): 1699 - 1711.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
K. Rodgers, B. McMahon, D. Mitchell, D. Sadlier, and C. Godson
Lipoxin A4 Modifies Platelet-Derived Growth Factor-Induced Profibrotic Gene Expression in Human Renal Mesangial Cells
Am. J. Pathol., September 1, 2005; 167(3): 683 - 694.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. P. Denton, G. E. Lindahl, K. Khan, X. Shiwen, V. H. Ong, N. J. Gaspar, K. Lazaridis, D. R. Edwards, A. Leask, M. Eastwood, et al.
Activation of Key Profibrotic Mechanisms in Transgenic Fibroblasts Expressing Kinase-deficient Type II Transforming Growth Factor-{beta} Receptor (T{beta}RII{Delta}k)
J. Biol. Chem., April 22, 2005; 280(16): 16053 - 16065.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
Y. Chen, D. J. Abraham, X. Shi-wen, J. D. Pearson, C. M. Black, K. M. Lyons, and A. Leask
CCN2 (Connective Tissue Growth Factor) Promotes Fibroblast Adhesion to Fibronectin
Mol. Biol. Cell, December 1, 2004; 15(12): 5635 - 5646.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 2004 by The American Society for Cell Biology. Terms of copyright protection, warranties, and disclaimers.